New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 10, 2014
10:26 EDTANF, STI, TGT, VTR, WLH, CNQ, AVY, BIDU, LM, ATK, QLIK, MSFT, APAM, BBRY, BMY, CQP, INCY, IRWD, JNS, LRY, M, AYIOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Abercrombie & Fitch (ANF) upgraded to Buy from Neutral at Janney Capital... Artisan Partners (APAM) upgraded to Buy from Neutral at Goldman... BlackBerry (BBRY) upgraded to Sector Perform from Underperform at RBC Capital... Bristol-Myers (BMY) upgraded to Overweight from Equal Weight at Barclays... Cheniere Energy Partners LP (CQP) upgraded to Buy from Neutral at Citigroup... Incyte (INCY) upgraded to Overweight from Equal Weight at Barclays... Ironwood (IRWD) upgraded to Outperform from Market Perform at BMO Capital... Janus Capital (JNS) upgraded to Neutral from Sell at Goldman... Liberty Property (LRY) upgraded to Buy from Neutral at UBS... Macy's (M) upgraded to Buy from Neutral at Goldman... Microsoft (MSFT) upgraded to Overweight from Equal Weight at Barclays... Qlik Technologies (QLIK) upgraded to Buy from Hold at Jefferies... SunTrust (STI) upgraded to Conviction Buy from Buy at Goldman... Target (TGT) upgraded to Buy from Neutral at Goldman... Ventas (VTR) upgraded to Buy from Neutral at UBS... William Lyon Homes (WLH) upgraded to Overweight from Neutral at JPMorgan... Canadian Natural (CNQ) upgraded to Outperform from Market Perform at BMO Capital... Avery Dennison (AVY) upgraded at Topeka... Baidu (BIDU) upgraded to Buy from Hold at Maxim... ATK (ATK) upgraded to Buy from Hold at Argus... Legg Mason (LM) upgraded to Neutral from Negative at Susquehanna... Acuity Brands (AYI) upgraded to Neutral from Underperform at Wedbush.
News For ANF;APAM;BBRY;BMY;CQP;INCY;IRWD;JNS;LRY;M;MSFT;QLIK;STI;TGT;VTR;WLH;CNQ;AVY;BIDU;LM;ATK;AYI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>
October 9, 2014
09:38 EDTMSFTActive equity options trading on open
Subscribe for More Information
09:01 EDTMSFTSony moves step further toward sale of PS4 in China, WSJ says
Sony (SNE), which seeks to join Microsoft (MSFT) in selling video game consoles in China, may see a partner company start packaging its consoles in the nation in December, said The Wall Street Journal, citing a filing posted by a Sony local partner on the official website of Shanghai’s free-trade zone. A Sony spokesperson said the facility's ability to package 200,000 consoles a year, which was communicated in the filing, does not represent an actual business plan and declined to comment further on Sony’s plans. Reference Link
08:53 EDTMSFTAbout 1,000 workers went on strike for several hours at Foxconn plant, WSJ says
Subscribe for More Information
08:02 EDTQLIKQlik Technologies announces partnership with Fujitsu
Subscribe for More Information
08:01 EDTTGTTarget CEO hands-on with Canadian turnaround, Globe and Mail says
Brian Cornell, the new CEO of Target, told The Globe and Mail in an interview that he is taking a hands-on approach to repairing the company’s Canadian business and that he will travel north on a “regular” basis to oversee the turnaround. Reference Link
07:25 EDTAYIAcuity Brands upgraded at Oppenheimer
Subscribe for More Information
06:42 EDTMSFTMicrosoft CEO admits 'mistakes' with Windows 8, Business Insider reports
Subscribe for More Information
06:41 EDTMSFTMicrosoft initiated with a Market Perform at BMO Capital
Subscribe for More Information
06:34 EDTAYIAcuity Brands upgraded to Outperform from Perform at Oppenheimer
06:31 EDTMSFTFiling says Sony to begin console packaging in China, Bloomberg says
A filing on the website of the China Pilot Free Trade Zone said that Sony (SNE) is aiming to begin packaging over 200K new video game consoles starting in December in China, according to Bloomberg, citing the filing which was verified as authentic by a spokesman for Sony Computer Entertainment. The company is looking to accumulate sales in the country as the end of a 14-year ban on the devices approaches. Microsoft (MSFT) already began selling Xbox Ones in China. Reference Link
06:24 EDTMSFTMicrosoft rumored to cancel Surface tablet business, DigiTimes reports
Microsoft may be planning to cancel the Surface tablet business as it continues to see weak sales for its Surface Pro 3 tablet, reports DigiTimes. According to sources from the upstream supply chain, the first and second generation Surface tablets are estimated to have created losses of about $1.7B. Reference Link
October 8, 2014
16:56 EDTMSFTGartner says worldwide PC shipments in Q3 declined 0.5%
Subscribe for More Information
13:43 EDTMDepartment stores fall after J.C. Penney cuts view due to difficult environment
Subscribe for More Information
11:13 EDTMMacy's October volatility increases as shares pull back
Subscribe for More Information
11:05 EDTJNSJanus fund managed by Gross brought in $66.4M, WSJ reports
Subscribe for More Information
09:23 EDTMCitigroup to hold a tour
Athletic Footwear Mall Tour travels to Roosevelt Field Mall, Garden City, New York on October 8.
08:03 EDTBMYBristol-Myers resolves outstanding U.S. litigation on efavirenz
Bristol-Myers Squibb Company says it has "successfully resolved all outstanding U.S. patent litigation relating to efavirenz, an active ingredient contained in our Sustiva -- efavirenz -- and Atripla products. Accordingly, we believe that loss of exclusivity in the U.S. for efavirenz should not occur until December 2017. Bristol-Myers Squibb remains committed to delivering our medicines and to developing new and innovative treatments to help patients prevail over serious disease. Atripla is currently the #1 prescribed U.S. regimen in its category, with over 8 million prescriptions written since its launch in 2006. Earlier this year the company submitted a new drug application to the U.S. Food and Drug Administration for a fixed-dose combination of atazanavir sulfate and cobicistat, an investigational pharmacokinetic enhancer. In addition, studies are ongoing for new treatments including an HIV-1 attachment inhibitor, an HIV-1 maturation inhibitor and an anti-PD-L1. The establishment of intellectual property rights allows Bristol-Myers Squibb to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. We will continue to defend our intellectual property rights against infringement as we remain focused on providing a deep and broad portfolio of innovative medicines to patients around the world."
07:18 EDTBMYInfectious Diseases Society of America to hold a conference
ID Week 2014 is being held in Philadelphia on October 8-12.
06:28 EDTSTIM&T Bank, SunTrust may miss Q3 expectations, says Citigroup
Subscribe for More Information
06:13 EDTMSFTNon-Apple notebook, tablet demand to be weak till 2Q15, DigiTimes reports
Demand for non-Apple (AAPL) notebooks and tablets may remain weak until the second quarter of 2015, reports DigiTimes. Citing Taiwan makers, the pressure due to booming sales from Apple products may decrease sales until Microsoft (MSFT) launches Windows 10 next year. Demand for Samsung (SSNLF), Sony (SNE) , And HTC smartphones have also dropped worldwide recently. Reference Link
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use